In response to the pharmaceutical industry stepping back from antibiotic discovery, multiple public efforts, including the JPIAMR and IMI ND4BB, as well as the efforts of Biomedical Science (BMS) European Research Infrastructures community have stepped in to fill the gap.
In this project, we will set up a knowledge sharing Network, Translocation-transfer (TT) bringing together experts from two major publicly funded programs, with the goal to improve the process of academically driven antibiotic drug discovery by capitalising on recently gained insights into a key bottleneck in anti-bacterial research, namely how compound penetration properties determine efficacy and resistance properties.
The JPIAMR is establishing a Virtual Research Institute on antimicrobial resistance (the JPIAMR-VRI). A virtual platform that will increase coordination, improve visibility of the AMR research networks, research performing institutes/centres and infrastructures, and facilitate knowledge exchange and capacity development across the globe, covering the full One Health spectrum.
This project has been supported under the framework of the Joint Programming Initiative on Antimicrobial Resistance.
We thank the JPIAMR-VRI for continuous support and funding.